Related Experiment Video
Updated: Aug 3, 2025

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
Published on: February 10, 2023
Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports
Ken Kanazawa1, Shogo Suzuki1, Tatsuro Inaba1
1Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan.
Ceftriaxone (CTRX) can cause biliary pseudolithiasis, particularly in elderly patients with type 1 diabetes mellitus (T1DM). Caution is advised when prescribing CTRX to this vulnerable population, especially those with diabetic autonomic neuropathy.
Area of Science:
- Pharmacology
- Endocrinology
- Gastroenterology
Background:
- Biliary pseudolithiasis is a known complication of ceftriaxone (CTRX) treatment.
- The specific risk in elderly patients with type 1 diabetes mellitus (T1DM) remains unclear.
- Diabetic autonomic neuropathy is a common comorbidity in elderly T1DM patients.
Observation:
- Two elderly female patients with T1DM presented with conditions requiring CTRX treatment.
- Case 1: A 78-year-old with T1DM and diabetic autonomic neuropathy developed biliary pseudolithiasis and cholecystitis on day 8 of CTRX therapy.
- Case 2: An 80-year-old with T1DM developed asymptomatic biliary pseudolithiasis and gastroparesis after a week of CTRX treatment.
Findings:
- Ceftriaxone (CTRX) administration was associated with the development of biliary pseudolithiasis in both elderly T1DM patients.
- The findings suggest a potential link between CTRX use and biliary pseudolithiasis in this specific demographic.
- Diabetic autonomic neuropathy may be a contributing factor or indicator of increased risk.
Implications:
- Ceftriaxone (CTRX) should be used with caution in elderly patients with type 1 diabetes mellitus (T1DM).
- Particular vigilance is recommended for T1DM patients who also have diabetic autonomic neuropathy.
- Further research is warranted to elucidate the mechanisms and confirm the risk in this population.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Endoscopic Procedures V: ERCP
Patient...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Urinary Tract Calculi III: Medical Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
